TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
PNTG

Pennant Group Inc

Healthcare · Medical Care Facilities

40.00$ -5.8% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Pennant Group Inc (PNTG)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 95.1% of the shares are freely tradable; institutional investors hold 95.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 95.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 5.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 95.1%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 2.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 35Mio.

Largest Shareholders

Institutions

Institutions PNTG
Name Stake (%) Shares Change (%) Date
BlackRock Inc 7.78 2,716,065 +0.1 03/31/2026
Van Berkom and Associates Inc 6.78 2,369,269 -55.6 06/30/2026
Wasatch Advisors LP 5.35 1,870,178 +31.8 06/30/2026
Turtle Creek Asset Management Inc. 4.53 1,582,823 +12,075.6 03/31/2026
Vanguard Capital Management, LLC 4.15 1,450,968 +0.0 03/31/2026
Paradigm Capital Management, Inc. 4.02 1,402,800 -0.4 06/30/2026
Arnhold & S. Bleichroeder Advisers, LLC 3.27 1,141,000 +164.7 06/30/2026
FMR Inc 3.16 1,102,624 +5.7 03/31/2026

Funds

Funds PNTG
Name Stake (%) Shares Change (%) Date
Van Berkom Sm-Cap Eq 6.50 2,269,541 -12.1 06/30/2026
Vanguard MStar Total Stk Mkt Idx Invest 3.00 1,049,539 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings PNTG
Person Role Shares Value As of Type
Snapper Suzanne D. Director 230,364 9,214,560 $ Jul 15, 2026 direct
Nackel John G. Director 174,565 6,982,600 $ Jul 15, 2026 direct
Christensen Christopher R. Director 145,991 5,839,640 $ Jul 15, 2026 direct
Smith Barry M Director 102,499 4,099,960 $ Jul 15, 2026 direct
Guerisoli Brent Chief Executive Officer 99,544 3,981,760 $ Aug 6, 2026 direct
Lamb Scott E Director 58,935 2,357,400 $ Jul 15, 2026 direct
Covey Stephen M R Director 44,050 1,762,000 $ Jul 15, 2026 direct
Morris Gregory K Sr. Director 37,300 1,492,000 $ Jul 15, 2026 direct
Cheney Kirk Sterling EVP, GC and Corp Secy 18,401 736,040 $ Aug 6, 2026 direct
Steik Jason Paul Chief Clinical Officer 15,106 604,240 $ Aug 6, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 6, 2026 Steik Jason Paul Chief Clinical Officer Sell 1,394 38.52 53,700
Aug 6, 2026 Guerisoli Brent Chief Executive Officer Sell 4,285 38.52 165,067
Aug 6, 2026 Cheney Kirk Sterling EVP, GC and Corp Secy Sell 1,393 38.52 53,661
Jul 15, 2026 Morris Gregory K Sr. Director Other 1,900 0.00
Jul 15, 2026 Snapper Suzanne D. Director Other 1,900 0.00
Jul 15, 2026 Nackel John G. Director Other 1,900 0.00
Jul 15, 2026 Christensen Christopher R. Director Other 1,900 0.00
Jul 15, 2026 Lamb Scott E Director Other 2,400 0.00
Jul 15, 2026 Smith Barry M Director Other 1,900 0.00
Jul 15, 2026 Covey Stephen M R Director Other 1,900 0.00
Jul 10, 2026 Guerisoli Brent Chief Executive Officer Sell 3,159 41.57 131,304
Jul 10, 2026 Guerisoli Brent Chief Executive Officer Other 6,248 4.54 28,366
Jul 7, 2026 Guerisoli Brent Chief Executive Officer Sell 3,165 40.51 128,214
Jul 7, 2026 Guerisoli Brent Chief Executive Officer Other 6,249 4.54 28,370

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?